Bruno Silvestrini

This inventor holds 30 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., Aboca S.p.a. Societa' Agricola, Angelini Pharmaceuticals. Active years: 1978-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruno Silvestrini. Retrieved from https://idiyas.com/inventor/bruno-silvestrini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 2)

% Patents Active = 96.7

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 1.5

ph-index = 9

Forward Citations = 329(Granted Patents)

Location History:

00179 Rome, IT (2001)
Rome, IT (1978 - 2021)

Company Filing History:

21 out of 106

Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.

patents

1 out of 16

Aboca S.p.a. Societa' Agricola

patents

1 out of 4

Angelini Pharmaceuticals

patents

4. 1 out of 1

Aziende Chimiche Riunite

Instituto Ricerca Francesco Angelini S.p.a.

patent

8. 3 out of 834,513

Other

patents

Years Active: 1978-2021

Loading Chart...

Areas of Expertise:

Tricalcium Phosphate

Hyaluronic Acid

Autoimmune Disease

Indazole Derivatives

Cataract Treatment

Hair Growth

Parkinsonism

Ophthalmic Use

Analgesics

Tolerance Inhibition

Extrapyramidal Syndromes

Dyspepsia Treatment

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10973850 - Composition comprising tricalcium phosphate and gelatin for use in a method for the treatment of dyspepsia and related disorders (2021-04-13),

2. 8147878 - Water insoluble helychrisum extract, process for preparing the same and uses thereof (2012-04-03),

3. 6269554 - Combined pronation and supination control plantar insert for shoes (2001-08-07),

4. 6224857 - Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics (2001-05-01),

5. 6001865 - 3-substituted 1-benzyl-1H-indazole derivatives as antifertility agents (1999-12-14),

6. 5284750 - Serum proteins related to autoimmune disease (1994-02-08),

7. 5278183 - Method for the treatment of autoimmune diseases (1994-01-11),

8. 5258312 - Serum proteins used to detect autoimmune disease (1993-11-02),

9. 5112986 - 1-benzyl-3-hydroxymethyl-indazole compounds and derivatives (1992-05-12),

10. 5093348 - Pharmaceutical composition for topical ophthalmic use having improved (1992-03-03),

11. 5047509 - Abnormally glycosylated variants of a.sub.2 macroglobulin (1991-09-10),

12. 5041446 - Method for inhibiting the development of tolerance in the analgesic (1991-08-20),

13. 4999367 - Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic (1991-03-12),

14. 4906632 - Method of preventing myocardial infarction and acute cerebral ischaemia (1990-03-06),

15. 4749684 - Method for increasing hair growth (1988-06-07),

Title: Inventor Bruno Silvestrini

Introduction: Bruno Silvestrini is a renowned inventor based in Rome, Italy, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Bruno Silvestrini holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced medical devices.

Career Highlights: With a career spanning over two decades, Silvestrini has worked with leading research institutions and universities to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Bruno Silvestrini has collaborated with multinational companies, startups, and fellow inventors to bring his ideas to life and commercialize his inventions successfully.

Conclusion: Bruno Silvestrini's passion for innovation and his dedication to creating solutions for the future continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.